Jan 12, 2026
Virginia Foxx- Amount
- $1,001 to $15,000
- Filed
- Feb 6, 2026
Congress ticker disclosure profile
As of July 20 at 8:00 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference PSA. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
19
Member filers
10
Disclosed ranges
$384K
Most active member desks
11 sells vs 8 buys
Democrat · House · CA-31
Democrat · Senate · OR
Democrat · Senate · RI
Democrat · House · NY-10
Democrat · Senate · WA
Republican · House · NC-5
Republican · Senate · OK
Republican · House · NY-27
Democrat · House · MN-3
Republican · House · MI-10
Latest trade Mar 27, 2026
Jan 12, 2026
Virginia FoxxDec 19, 2025
Gilbert Ray Cisneros Jr.Aug 5, 2025
Gilbert Ray Cisneros Jr.Jul 12, 2023
Daniel S. GoldmanAug 14, 2020
Ron WydenAug 5, 2020
Ron WydenJun 15, 2017
Patty MurrayDec 23, 2016
Sheldon WhitehouseAug 18, 2016
Sheldon Whitehouse| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jan 12, 2026 | Virginia Foxx | Sell | $1,001 to $15,000 | Feb 6, 2026 | Open card |
| Dec 19, 2025 | Gilbert Ray Cisneros Jr. | Sell | $1,001 to $15,000 | Jan 12, 2026 | Open card |
| Aug 5, 2025 | Gilbert Ray Cisneros Jr. | Sell | $1,001 to $15,000 | Sep 12, 2025 | Open card |
| Jul 12, 2023 | Daniel S. Goldman | Sell | $50,001 to $100,000 | Aug 13, 2023 | Open card |
| Aug 14, 2020 | Ron Wyden | Buy | $15,001 to $50,000 | Aug 29, 2020 | Open card |
| Aug 5, 2020 | Ron Wyden | Buy | $15,001 to $50,000 | Aug 29, 2020 | Open card |
| Jun 15, 2017 | Patty Murray | Sell | $1,001 to $15,000 | Jun 22, 2017 | Open card |
| Dec 23, 2016 | Sheldon Whitehouse | Sell | $15,001 to $50,000 | Jan 11, 2017 | Open card |
| Aug 18, 2016 | Sheldon Whitehouse | Buy | $1,001 to $15,000 | Sep 9, 2016 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 19 of 19 filed rows include disclosed amount ranges (100%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.